421 related articles for article (PubMed ID: 28383481)
1. Strange Bedfellows: Nuclear Factor, Erythroid 2-Like 2 (Nrf2) and Hypoxia-Inducible Factor 1 (HIF-1) in Tumor Hypoxia.
Toth RK; Warfel NA
Antioxidants (Basel); 2017 Apr; 6(2):. PubMed ID: 28383481
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia, oxidative stress, and the interplay of HIFs and NRF2 signaling in cancer.
Bae T; Hallis SP; Kwak MK
Exp Mol Med; 2024 Mar; 56(3):501-514. PubMed ID: 38424190
[TBL] [Abstract][Full Text] [Related]
3. Impairment of HIF-1α-mediated metabolic adaption by NRF2-silencing in breast cancer cells.
Lee S; Hallis SP; Jung KA; Ryu D; Kwak MK
Redox Biol; 2019 Jun; 24():101210. PubMed ID: 31078780
[TBL] [Abstract][Full Text] [Related]
4. Effects of acute hypoxia exposure with different durations on activation of Nrf2-ARE pathway in mouse skeletal muscle.
Ji W; Wang L; He S; Yan L; Li T; Wang J; Kong AT; Yu S; Zhang Y
PLoS One; 2018; 13(12):e0208474. PubMed ID: 30513114
[TBL] [Abstract][Full Text] [Related]
5. HIF-1 alpha signaling is augmented during intermittent hypoxia by induction of the Nrf2 pathway in NOX1-expressing adenocarcinoma A549 cells.
Malec V; Gottschald OR; Li S; Rose F; Seeger W; Hänze J
Free Radic Biol Med; 2010 Jun; 48(12):1626-35. PubMed ID: 20347035
[TBL] [Abstract][Full Text] [Related]
6. Blockage of Nrf2 suppresses the migration and invasion of esophageal squamous cell carcinoma cells in hypoxic microenvironment.
Shen H; Yang Y; Xia S; Rao B; Zhang J; Wang J
Dis Esophagus; 2014; 27(7):685-92. PubMed ID: 24028437
[TBL] [Abstract][Full Text] [Related]
7. HIF-1 and NRF2; Key Molecules for Malignant Phenotypes of Pancreatic Cancer.
Hamada S; Matsumoto R; Masamune A
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053572
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible factor-1 in human breast and prostate cancer.
Kimbro KS; Simons JW
Endocr Relat Cancer; 2006 Sep; 13(3):739-49. PubMed ID: 16954428
[TBL] [Abstract][Full Text] [Related]
9. Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer.
Yasuda H
Nitric Oxide; 2008 Sep; 19(2):205-16. PubMed ID: 18503779
[TBL] [Abstract][Full Text] [Related]
10. Differential transcriptional regulation of hypoxia-inducible factor-1α by arsenite under normoxia and hypoxia: involvement of Nrf2.
Al Taleb Z; Petry A; Chi TF; Mennerich D; Görlach A; Dimova EY; Kietzmann T
J Mol Med (Berl); 2016 Oct; 94(10):1153-1166. PubMed ID: 27286880
[TBL] [Abstract][Full Text] [Related]
11. Andrographolide inhibits hypoxia-induced HIF-1α-driven endothelin 1 secretion by activating Nrf2/HO-1 and promoting the expression of prolyl hydroxylases 2/3 in human endothelial cells.
Lin HC; Su SL; Lu CY; Lin AH; Lin WC; Liu CS; Yang YC; Wang HM; Lii CK; Chen HW
Environ Toxicol; 2017 Mar; 32(3):918-930. PubMed ID: 27297870
[TBL] [Abstract][Full Text] [Related]
12. In vivo hyperoxia induces hypoxia-inducible factor-1α overexpression in LNCaP tumors without affecting the tumor growth rate.
Terraneo L; Virgili E; Caretti A; Bianciardi P; Samaja M
Int J Biochem Cell Biol; 2014 Jun; 51():65-74. PubMed ID: 24704415
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factor (HIF) in human tumorigenesis.
Mabjeesh NJ; Amir S
Histol Histopathol; 2007 May; 22(5):559-72. PubMed ID: 17330811
[TBL] [Abstract][Full Text] [Related]
14. Targeting Hypoxia-Inducible Factor-1 (HIF-1) in Cancer: Emerging Therapeutic Strategies and Pathway Regulation.
Qannita RA; Alalami AI; Harb AA; Aleidi SM; Taneera J; Abu-Gharbieh E; El-Huneidi W; Saleh MA; Alzoubi KH; Semreen MH; Hudaib M; Bustanji Y
Pharmaceuticals (Basel); 2024 Feb; 17(2):. PubMed ID: 38399410
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow-derived mesenchymal stem cells induced by inflammatory cytokines produce angiogenetic factors and promote prostate cancer growth.
Yang KQ; Liu Y; Huang QH; Mo N; Zhang QY; Meng QG; Cheng JW
BMC Cancer; 2017 Dec; 17(1):878. PubMed ID: 29268703
[TBL] [Abstract][Full Text] [Related]
16. The Interplay Between Tumor Suppressor p53 and Hypoxia Signaling Pathways in Cancer.
Zhang C; Liu J; Wang J; Zhang T; Xu D; Hu W; Feng Z
Front Cell Dev Biol; 2021; 9():648808. PubMed ID: 33681231
[TBL] [Abstract][Full Text] [Related]
17. Mutant p53 and Cellular Stress Pathways: A Criminal Alliance That Promotes Cancer Progression.
D'Orazi G; Cirone M
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31052524
[TBL] [Abstract][Full Text] [Related]
18. Cross Talk in HEK293 Cells Between Nrf2, HIF, and NF-κB Activities upon Challenges with Redox Therapeutics Characterized with Single-Cell Resolution.
Johansson K; Cebula M; Rengby O; Dreij K; Carlström KE; Sigmundsson K; Piehl F; Arnér ES
Antioxid Redox Signal; 2017 Feb; 26(6):229-246. PubMed ID: 26415122
[TBL] [Abstract][Full Text] [Related]
19. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion.
Brahimi-Horn C; Pouysségur J
Bull Cancer; 2006 Aug; 93(8):E73-80. PubMed ID: 16935775
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway.
Tan C; de Noronha RG; Roecker AJ; Pyrzynska B; Khwaja F; Zhang Z; Zhang H; Teng Q; Nicholson AC; Giannakakou P; Zhou W; Olson JJ; Pereira MM; Nicolaou KC; Van Meir EG
Cancer Res; 2005 Jan; 65(2):605-12. PubMed ID: 15695405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
